Burosumab
Burosumab (KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
Product Specifications
CAS Number
1610833-03-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15353644 1 Vial
Lentiviral human HSD11B1L shRNA (UAS) - Lentiviral human HSD11B1L shRNA (UAS, RFP) plasmid
Ask
View Details MPC0511K Each
Magic™ Membrane Protein Human GABRA3 (Gamma-aminobutyric acid type A receptor subunit alpha3) Full Length
Ask
View Details R0495-03A-ML550 100 µL
RAF-1, phosphorylated (Ser233) (RAF Proto-Oncogene Serine/Threonine-Protein Kinase, Proto-Oncogene c-RAF, cRaf, RAF1, RAF) (MaxLight 550) discontinued
Ask
View Details 